Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.Barcelona, Catalonia, Spain
Disclosure information not submitted.
Paper 28 - A PHASE 4, MULTICENTER, GLOBAL CLINICAL TRIAL TO EVALUATE DISCONTINUATION AND RECHALLENGE OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR PREVIOUSLY TREATED WITH PEXIDARTINIB
Thursday, November 2, 20234:00 PM – 5:30 PM